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MicroRNAs (miRNAs) are ~22 nt single-stranded, non-
protein-coding RNAs that generally negatively regulate
their target mRNAs at a posttranscriptional level. Differ-
ential expression of miRNAs has been observed in many
human cancers. To study their potential role in the
pathogenesis of human papillomavirus (HPV) type 16-
associated cervical neoplasia and cancer, we analyzed
miRNA expression in cervical tissue from the normal
cervix, moderate/severe dysplasia, and invasive squa-
mous cell carcinoma. Using RNA from 6 cervical can-
cers, 3 dysplasias, and 4 normal samples and the
TaqMan® MicroRNA Arrays, we found that 18 miRNAs
were overexpressed and 2 underexpressed in cervical
cancer compared to the normal cervical tissue (p<0.05).
We further found that 9 miRNAs (miRs-16, 21, 106b,
124, 135b, 223, 301b, 449a, and 141) were consistently
overexpressed and 2 miRNAs (miRs-218 and 433) were
consistently underexpressed in cervical cancer compared
to the normal tissue. MiRNA expression in dysplasia
samples was most similar to the normal tissue, with the
exception of the overexpression of miR-16, miR-141,
and miR-449a, and the underexpression of miR-218 and
miR-433. Our results suggest that five miRNAs may
have potential as markers for progression of dysplasia to
invasive cervical disease.
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